Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
Biotechnology and Bioengineering
|
December 11, 1999
Inhibition of caspase activity delays apoptosis in a transfected NS/0 myeloma cell line
S L McKenna, T G Cotter
Advances in Cancer Research
|
January 1, 1997
Functional aspects of apoptosis in hematopoiesis and consequences of failure
S L McKenna, T G Cotter
Leukemia
|
August 30, 2002
High Bcr-Abl expression prevents the translocation of Bax and Bad to the mitochondrion
K Keeshan, T G Cotter, S L McKenna
Advances in Biochemical Engineering/Biotechnology
|
October 2, 1998
Molecular mechanisms of programmed cell death
S L McKenna, A J McGowan, T G Cotter
Cancer Medicine
|
September 17, 2024
Expression of MxA in esophageal cancer cell lines can influence sensitivity to chemotherapeutic agents but this does not require apoptosis
R M Hayes, T R O'Donovan, S L McKenna
British Journal of Cancer
|
June 6, 2000
Activation of SAPK/JNK by camptothecin sensitizes androgen-independent prostate cancer cells to Fas-induced apoptosis
A P Costa-Pereira, S L McKenna, T G Cotter
Leukemia
|
December 26, 2001
Elevated Bcr-Abl expression levels are sufficient for a haematopoietic cell line to acquire a drug-resistant phenotype
K Keeshan, K I Mills, T G Cotter, et al.
International Journal of Cancer
|
July 17, 2007
Beta-catenin transcriptional activity is inhibited downstream of nuclear localisation and is not influenced by IGF signalling in oesophageal cancer cells
B Kiely, R T O'Donovan, S L McKenna, et al.
The Oncologist
|
October 21, 2000
Molecular abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis
A Di Bacco, K Keeshan, S L McKenna, et al.
Leukemia Research
|
August 8, 2001
Inhibition of PI3-kinase sensitises HL60 human leukaemia cells to both chemotherapeutic drug- and Fas-induced apoptosis by a JNK independent pathway
D M O'Gorman, S L McKenna, A J McGahon, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
Biotechnology and Bioengineering
|
December 11, 1999
Inhibition of caspase activity delays apoptosis in a transfected NS/0 myeloma cell line
S L McKenna, T G Cotter
Advances in Cancer Research
|
January 1, 1997
Functional aspects of apoptosis in hematopoiesis and consequences of failure
S L McKenna, T G Cotter
Leukemia
|
August 30, 2002
High Bcr-Abl expression prevents the translocation of Bax and Bad to the mitochondrion
K Keeshan, T G Cotter, S L McKenna
Advances in Biochemical Engineering/Biotechnology
|
October 2, 1998
Molecular mechanisms of programmed cell death
S L McKenna, A J McGowan, T G Cotter
Cancer Medicine
|
September 17, 2024
Expression of MxA in esophageal cancer cell lines can influence sensitivity to chemotherapeutic agents but this does not require apoptosis
R M Hayes, T R O'Donovan, S L McKenna
British Journal of Cancer
|
June 6, 2000
Activation of SAPK/JNK by camptothecin sensitizes androgen-independent prostate cancer cells to Fas-induced apoptosis
A P Costa-Pereira, S L McKenna, T G Cotter
Leukemia
|
December 26, 2001
Elevated Bcr-Abl expression levels are sufficient for a haematopoietic cell line to acquire a drug-resistant phenotype
K Keeshan, K I Mills, T G Cotter, et al.
International Journal of Cancer
|
July 17, 2007
Beta-catenin transcriptional activity is inhibited downstream of nuclear localisation and is not influenced by IGF signalling in oesophageal cancer cells
B Kiely, R T O'Donovan, S L McKenna, et al.
The Oncologist
|
October 21, 2000
Molecular abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis
A Di Bacco, K Keeshan, S L McKenna, et al.
Leukemia Research
|
August 8, 2001
Inhibition of PI3-kinase sensitises HL60 human leukaemia cells to both chemotherapeutic drug- and Fas-induced apoptosis by a JNK independent pathway
D M O'Gorman, S L McKenna, A J McGahon, et al.
Page
of 4